Skip to content

If you’re looking for talking points to help explain the COVID-19 Bivalent Booster, you can find them here.

CDC HAN Health Advisory| Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir

December 14, 2022 the CDC released a HAN Health Advisory regarding Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir.

Find out more at: https://emergency.cdc.gov/han/2022/han00482.asp

udW GC a
Scroll To Top expand_less

Sign Up For Email Updates